Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in Oncology...
Source: globenewswire.com
📰 Nasdaq Tern News
Page 5 - Nasdaq Tern News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Tern. Real-time updates on events, politics, business and more.
Terns Announces Pricing of $75 Million Public Offering
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
New York United States Terns Pharmaceuticals Inc Broadridge Financial Solutions Company Nasdaq Terns Pharmaceuticals
Source: globenewswire.com
Terns Pharmaceuticals Reports Second Quarter 2022 Financial
TERN-701 (allosteric BCR-ABL inhibitor) advances into Phase 1 trial for CML in ChinaIND-enabling activities for TERN-601 (GLP-1R agonist) remain on track;...
Canaccord Genuity Sen Sundaram Radhika Tripuraneni Kerry Russell Terns Pharmaceuticals Inc Company Nasdaq
Source: globenewswire.com
Terns Pharmaceuticals (NASDAQ:TERN) Rating Lowered to Sell at Zacks Investment Research
Zacks Investment Research downgraded shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Thursday morning, Zacks.com reports. According to Zacks, “Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for […]
United States Terns Pharmaceuticals Inc Zacks Investment Research America Corp Terns Pharmaceuticals Wells Fargo Company
Source: etfdailynews.com